Related Experiment Videos
Monocyte-derived dendritic cells in bipolar disorder
Esther M Knijff1, Cindy Ruwhof, Harm J de Wit
1Department of Immunology, Erasmus Medical Centre, Rotterdam, The Netherlands. e.knijff@erasmusmc.nl
Biological Psychiatry
|September 17, 2005
Summary
Bipolar disorder impairs dendritic cell (DC) function, but lithium treatment in patients restores DC activity. This study investigated how lithium affects monocyte-derived DC in bipolar disorder patients.
Area of Science:
- Immunology
- Neuroscience
- Cell Biology
Background:
- Dendritic cells (DCs) are crucial immune regulators.
- Immune system dysfunction is observed in bipolar disorder.
- Monocyte-derived DCs in bipolar disorder warrant investigation.
Purpose of the Study:
- To investigate the function of monocyte-derived dendritic cells (mo-DCs) in bipolar disorder.
- To assess the impact of lithium treatment on mo-DCs in bipolar disorder patients.
Main Methods:
- Monocytes were isolated from bipolar disorder patients and healthy controls.
- Monocytes were differentiated into DCs using standard culture methods.
- DC differentiation and function were analyzed, including T-cell stimulatory capacity, with and without lithium exposure.
Main Results:
- Bipolar disorder patients exhibited impaired mo-DC differentiation and reduced T-cell stimulation.
- In vivo lithium treatment normalized mo-DC function in bipolar disorder patients.
- In vitro lithium exposure at high concentrations suppressed mo-DC activation.
Conclusions:
- Dendritic cells display mild functional deficits in bipolar disorder.
- In vivo lithium treatment effectively restores and enhances mo-DC function in bipolar disorder.
- Lithium's therapeutic effect in bipolar disorder may involve immune system modulation via DCs.